13F filer · CIK 1892134
Frazier Life Sciences Management, L.P.
PALO ALTO, CA · filing since Q1 2022 · last filing Aug 14, 2026
Reported value
$4.6B
+$705.6M vs prior
Positions
41
New / sold out
6 / 3
Added / reduced
8 / 2
Turnover
8.0%
buys $338.3M · sells $349.6M
Top-10 weight
73.6%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | PARABILIS MEDICINES INC | +1,920,805 | – | +$52.6M |
| New | ACHIEVE LIFE SCIENCE INC | +7,614,836 | – | +$49.7M |
| Added | NEWAMSTERDAM PHARMA COMPANY | +1,145,128 | +6.8% | +$38.8M |
| Added | ALLOGENE THERAPEUTICS INC | +18,650,000 | +491.2% | +$38.8M |
| New | DESIGN THERAPEUTICS INC | +1,809,854 | – | +$26.2M |
| New | SHATTUCK LABS INC | +3,750,000 | – | +$26.0M |
| Added | ASCENDIS PHARMA A/S | +91,822 | +68.9% | +$24.5M |
| New | KAILERA THERAPEUTICS INC | +1,100,000 | – | +$24.2M |
| New | RELAY THERAPEUTICS INC | +1,015,693 | – | +$19.0M |
| Added | AURA BIOSCIENCES INC | +2,000,000 | +39.2% | +$14.2M |
4 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | BRIDGEBIO PHARMA INC | -1,900,000 | -55.1% | $-141.5M |
| Sold out | KALVISTA PHARMACEUTICALS INC | -4,961,108 | -100.0% | $-99.9M |
| Sold out | REVOLUTION MEDICINES INC | -675,686 | -100.0% | $-65.7M |
| Sold out | AGIOS PHARMACEUTICALS INC | -1,256,080 | -100.0% | $-42.5M |
| Reduced | TREVI THERAPEUTICS INC | -100 | -0.0% | $-1.9K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | MIRUM PHARMACEUTICALS INCCOM | 7,679,684 | $899.1M | 19.58% |
| 2 | NEWAMSTERDAM PHARMA COMPANYORDINARY SHARES | 18,088,902 | $613.0M | 13.35% |
| 3 | ERASCA INCCOM | 24,975,188 | $457.5M | 9.96% |
| 4 | MBX BIOSCIENCES INCCOM | 6,652,013 | $367.2M | 8.00% |
| 5 | ARCUTIS BIOTHERAPEUTICS INCCOM | 9,874,511 | $258.9M | 5.64% |
| 6 | TREVI THERAPEUTICS INCCOM | 9,939,447 | $185.4M | 4.04% |
| 7 | KRYSTAL BIOTECH INCCOM | 481,307 | $178.9M | 3.90% |
| 8 | MAZE THERAPEUTICS INCCOM | 5,032,915 | $150.2M | 3.27% |
| 9 | PHATHOM PHARMACEUTICALS INCCOM | 12,466,489 | $135.3M | 2.95% |
| 10 | PALVELLA THERAPEUTICS INC NECOM | 882,400 | $134.8M | 2.94% |
31 more rows. Subscribe for $29/month to see every row, download the data and use the API.